FR2751345B1 - HIGHLY PRODUCING PACKAGING LINES - Google Patents

HIGHLY PRODUCING PACKAGING LINES

Info

Publication number
FR2751345B1
FR2751345B1 FR9608889A FR9608889A FR2751345B1 FR 2751345 B1 FR2751345 B1 FR 2751345B1 FR 9608889 A FR9608889 A FR 9608889A FR 9608889 A FR9608889 A FR 9608889A FR 2751345 B1 FR2751345 B1 FR 2751345B1
Authority
FR
France
Prior art keywords
packaging lines
producing packaging
highly producing
highly
lines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9608889A
Other languages
French (fr)
Other versions
FR2751345A1 (en
Inventor
David Klatzmann
Jean Loup Salzmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Pierre et Marie Curie Paris 6
Original Assignee
Universite Pierre et Marie Curie Paris 6
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Pierre et Marie Curie Paris 6 filed Critical Universite Pierre et Marie Curie Paris 6
Priority to FR9608889A priority Critical patent/FR2751345B1/en
Priority to EP97932873A priority patent/EP0912723A1/en
Priority to JP10505665A priority patent/JP2000514652A/en
Priority to CA002262814A priority patent/CA2262814A1/en
Priority to PCT/FR1997/001250 priority patent/WO1998002529A1/en
Publication of FR2751345A1 publication Critical patent/FR2751345A1/en
Application granted granted Critical
Publication of FR2751345B1 publication Critical patent/FR2751345B1/en
Priority to US09/978,931 priority patent/US6872528B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10051—Methods of production or purification of viral material
    • C12N2740/10052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051—Methods of production or purification of viral material
    • C12N2740/13052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
FR9608889A 1996-07-16 1996-07-16 HIGHLY PRODUCING PACKAGING LINES Expired - Fee Related FR2751345B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9608889A FR2751345B1 (en) 1996-07-16 1996-07-16 HIGHLY PRODUCING PACKAGING LINES
EP97932873A EP0912723A1 (en) 1996-07-16 1997-07-09 Highly productive packaging lines
JP10505665A JP2000514652A (en) 1996-07-16 1997-07-09 Encapsidation system with high production capacity
CA002262814A CA2262814A1 (en) 1996-07-16 1997-07-09 Highly productive packaging lines_
PCT/FR1997/001250 WO1998002529A1 (en) 1996-07-16 1997-07-09 Highly productive packaging lines
US09/978,931 US6872528B2 (en) 1996-07-16 2001-10-15 Highly productive packaging lines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9608889A FR2751345B1 (en) 1996-07-16 1996-07-16 HIGHLY PRODUCING PACKAGING LINES

Publications (2)

Publication Number Publication Date
FR2751345A1 FR2751345A1 (en) 1998-01-23
FR2751345B1 true FR2751345B1 (en) 1998-09-18

Family

ID=9494105

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9608889A Expired - Fee Related FR2751345B1 (en) 1996-07-16 1996-07-16 HIGHLY PRODUCING PACKAGING LINES

Country Status (6)

Country Link
US (1) US6872528B2 (en)
EP (1) EP0912723A1 (en)
JP (1) JP2000514652A (en)
CA (1) CA2262814A1 (en)
FR (1) FR2751345B1 (en)
WO (1) WO1998002529A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4952500A (en) * 1999-06-01 2000-12-18 Chugai Seiyaku Kabushiki Kaisha Packaging cell
EP1059356B1 (en) * 1999-06-09 2005-11-02 Universite Pierre Et Marie Curie Paris Vi Replicating retroviral constructs, preparation and uses for gene delivery
EP1059357A1 (en) 1999-06-09 2000-12-13 Universite Pierre Et Marie Curie Paris Vi Replicating or semi-replicating retroviral constructs, preparation and uses for gene delivery
EP1201750A1 (en) 2000-10-26 2002-05-02 Genopoietic Synthetic viruses and uses thereof
US8129187B2 (en) * 2005-12-13 2012-03-06 Kyoto University Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2
EP4223769A3 (en) * 2005-12-13 2023-11-01 Kyoto University Nuclear reprogramming factor
US20090227032A1 (en) * 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
US8278104B2 (en) * 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
TW200819848A (en) * 2006-10-16 2008-05-01 Innolux Display Corp Backlight system and liquid crystal display using the same
JP2008307007A (en) * 2007-06-15 2008-12-25 Bayer Schering Pharma Ag Human pluripotent stem cell induced from human tissue-originated undifferentiated stem cell after birth
US9213999B2 (en) * 2007-06-15 2015-12-15 Kyoto University Providing iPSCs to a customer
EP2268809B1 (en) * 2008-05-02 2019-02-06 Kyoto University Method of nuclear reprogramming
EP2499241B8 (en) 2009-11-10 2018-02-21 The J. David Gladstone Institutes Methods of generating neural stem cells
EP2366776A1 (en) 2010-03-01 2011-09-21 Epixis A method for measuring viral infectivity
US9517250B2 (en) 2010-04-28 2016-12-13 The J. David Gladstone Institutes Methods for generating cardiomyocytes
GB201318347D0 (en) 2013-10-16 2013-11-27 Ucl Business Plc Retroviral vectors
WO2016164371A1 (en) 2015-04-07 2016-10-13 The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone Methods for inducing cell division of postmitotic cells
BR112021003897A2 (en) 2018-08-30 2021-05-25 Tenaya Therapeutics, Inc. reprogramming of cardiac cells with myocarin and asci1
EP3997226A1 (en) 2019-07-11 2022-05-18 Tenaya Therapeutics, Inc. Cardiac cell reprogramming with micrornas and other factors
EP4114421A1 (en) 2020-03-02 2023-01-11 Tenaya Therapeutics, Inc. Gene vector control by cardiomyocyte-expressed micrornas
US11781156B2 (en) 2020-10-09 2023-10-10 Tenaya Therapeutics, Inc. Plakophillin-2 gene therapy methods and compositions
WO2022131039A1 (en) 2020-12-14 2022-06-23 ユニバーサル・バイオ・リサーチ株式会社 Sample pooling device and sample pooling system

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665577A (en) * 1989-02-06 1997-09-09 Dana-Farber Cancer Institute Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof
US5470726A (en) * 1991-02-22 1995-11-28 Fred Hutchinson Cancer Research Center Retrovirus packaging and producer cell lines based on gibbon ape leukemia virus
ES2173082T3 (en) * 1991-08-07 2002-10-16 W French Anderson RETROVIRAL VECTORS CONTAINING INTERNAL RIBOSOME ENTRY SITES.
WO1993010218A1 (en) * 1991-11-14 1993-05-27 The United States Government As Represented By The Secretary Of The Department Of Health And Human Services Vectors including foreign genes and negative selective markers
FR2699191B1 (en) * 1992-12-16 1995-02-10 Univ Paris Curie New retroviral vectors, cell lines containing them, and their use in the treatment of tumors.
FR2707091B1 (en) * 1993-06-30 1997-04-04 Cohen Haguenauer Odile Retroviral vector for gene transfer and expression in eukaryotic cells.
FR2727429B1 (en) * 1994-11-30 1997-11-28 Haguenauer Odile Cohen ENCAPSIDATION LINES AND EXPRESSION VECTORS FOR TRANSCOMPLEMENTATION OF DEFECTIVE RETROVIRAL VECTORS
US5681746A (en) * 1994-12-30 1997-10-28 Chiron Viagene, Inc. Retroviral delivery of full length factor VIII

Also Published As

Publication number Publication date
US20020123146A1 (en) 2002-09-05
EP0912723A1 (en) 1999-05-06
CA2262814A1 (en) 1998-01-22
FR2751345A1 (en) 1998-01-23
US6872528B2 (en) 2005-03-29
JP2000514652A (en) 2000-11-07
WO1998002529A1 (en) 1998-01-22

Similar Documents

Publication Publication Date Title
FR2751345B1 (en) HIGHLY PRODUCING PACKAGING LINES
DE69633971D1 (en) packaging
DE69506252T2 (en) DISTRIBUTION PACKAGING
FI951637A (en) Packaging
ATE245584T1 (en) PACKAGING PROCEDURE
DE59607589D1 (en) N-ARYL-1,2,4-TRIAZOLINE-5-ONE
DE69701555T2 (en) Packaging box
DE69521923D1 (en) Anti-dream package
DE29501247U1 (en) Combination packaging
DK55997A (en) Packaging boxes
DE9413551U1 (en) Packaging box
DE69612015D1 (en) PACKAGING
FI98805B (en) Packaging
DE29516401U1 (en) packaging
KR960034482U (en) Strawberry packaging box
KR970023432U (en) Strawberry packaging box
UA2404S (en) CANDY BOX "HETMAN"
KR970046918U (en) Multifaceted package
KR970046923U (en) Tape-on-chip package
KR970046900U (en) Hi-pin package
SE9601757L (en) Packaging
DE29516081U1 (en) packaging
UA1258S (en) CHARUNKOVA PACKAGING
DE29507175U1 (en) packaging
SE9604080D0 (en) Packaging

Legal Events

Date Code Title Description
ST Notification of lapse